BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34999496)

  • 1. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.
    Dejthevaporn C; Wetchaphanphesat S; Pulkes T; Rattanasiri S; Engel AG; Witoonpanich R
    J Clin Neurosci; 2022 Feb; 96():85-89. PubMed ID: 34999496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine.
    Durmus H; Sticht H; Ceylaner S; Hashemolhosseini S; Deymeer F
    Acta Neurol Belg; 2021 Dec; 121(6):1755-1760. PubMed ID: 33030681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.
    Harper CM; Fukodome T; Engel AG
    Neurology; 2003 May; 60(10):1710-3. PubMed ID: 12771277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome.
    Peyer AK; Abicht A; Heinimann K; Sinnreich M; Fischer D
    Neuromuscul Disord; 2013 Jul; 23(7):571-4. PubMed ID: 23688972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
    Finlayson S; Spillane J; Kullmann DM; Howard R; Webster R; Palace J; Beeson D
    Muscle Nerve; 2013 Feb; 47(2):279-82. PubMed ID: 23281026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic heterogeneity in a large Thai slow-channel congenital myasthenic syndrome kinship.
    Witoonpanich R; Pulkes T; Dejthevaporn C; Yodnopklao P; Witoonpanich P; Wetchaphanphesat S; Brengman JM; Engel AG
    Neuromuscul Disord; 2011 Mar; 21(3):214-8. PubMed ID: 21316238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report.
    Gooneratne IK; Nandasiri S; Maxwell S; Webster R; Cossins J; Beeson D; Gunaratne K; Herath L; Senanayake S; Chang T
    J Neuromuscul Dis; 2021; 8(1):163-167. PubMed ID: 33216040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
    Webster R; Brydson M; Croxen R; Newsom-Davis J; Vincent A; Beeson D
    Neurology; 2004 Apr; 62(7):1090-6. PubMed ID: 15079006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine.
    Colomer J; Müller JS; Vernet A; Nascimento A; Pons M; Gonzalez V; Abicht A; Lochmüller H
    Neuromuscul Disord; 2006 May; 16(5):329-33. PubMed ID: 16621558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
    Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
    Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
    [No Abstract]   [Full Text] [Related]  

  • 12. A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
    Webster RG; Cossins J; Lashley D; Maxwell S; Liu WW; Wickens JR; Martinez-Martinez P; de Baets M; Beeson D
    Exp Neurol; 2013 Oct; 248():286-98. PubMed ID: 23797154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome.
    Eirís-Puñal J; Fuentes-Pita P; Gómez-Lado C; Pérez-Gay L; López-Vázquez A; Quintas-Rey R; Barros-Angueira F; Pardo J
    Rev Neurol; 2020 Sep; 71(6):221-224. PubMed ID: 32895905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
    Rodríguez Cruz PM; Ravenscroft G; Natera D; Carr A; Manzur A; Liu WW; Vella NR; Jericó I; Gonzalez-Quereda L; Gallano P; Montalto SA; Davis MR; Lamont PJ; Laing NG; Bourque P; Nascimento A; Muntoni F; Polavarapu K; Lochmüller H; Palace J; Beeson D
    Neuromuscul Disord; 2023 Feb; 33(2):161-168. PubMed ID: 36634413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.
    Zhu H; Grajales-Reyes GE; Alicea-Vázquez V; Grajales-Reyes JG; Robinson K; Pytel P; Báez-Pagán CA; Lasalde-Dominicci JA; Gomez CM
    Exp Neurol; 2015 Aug; 270():88-94. PubMed ID: 25448156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapsyn congenital myasthenic syndrome worsened by fluoxetine.
    Visser AC; Laughlin RS; Litchy WJ; Benarroch EE; Milone M
    Muscle Nerve; 2017 Jan; 55(1):131-135. PubMed ID: 27397848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine.
    Santos M; Cruz S; Peres J; Santos L; Tavares P; Basto JP; Salgado V; Valverde AH
    Neuromuscul Disord; 2018 Mar; 28(3):278-282. PubMed ID: 29395672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor.
    Deflorio C; Catalano M; Fucile S; Limatola C; Grassi F
    Muscle Nerve; 2014 Jan; 49(1):90-7. PubMed ID: 23559277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel epsilon subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome.
    Outteryck O; Richard P; Lacour A; Fournier E; Zéphir H; Gaudon K; Eymard B; Hantaï D; Vermersch P; Stojkovic T
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):450-1. PubMed ID: 19289485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.